The Manufacturers Life Insurance Company acquired a new position in HCA Healthcare, Inc. (NYSE:HCA – Free Report) during the 2nd quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The institutional investor acquired 80,299 shares of the company’s stock, valued at approximately $31,308,000.
Other institutional investors have also added to or reduced their stakes in the company. Brighton Jones LLC bought a new stake in shares of HCA Healthcare during the 4th quarter valued at $1,021,000. NewEdge Advisors LLC lifted its position in HCA Healthcare by 11.9% during the first quarter. NewEdge Advisors LLC now owns 3,859 shares of the company’s stock valued at $1,334,000 after purchasing an additional 409 shares in the last quarter. Sivia Capital Partners LLC raised its stake in shares of HCA Healthcare by 5.5% in the second quarter. Sivia Capital Partners LLC now owns 630 shares of the company’s stock worth $241,000 after buying an additional 33 shares during the period. Jump Financial LLC bought a new position in shares of HCA Healthcare during the 2nd quarter valued at approximately $2,073,000. Finally, Sei Investments Co. raised its stake in HCA Healthcare by 56.3% during the 2nd quarter. Sei Investments Co. now owns 136,589 shares of the company’s stock worth $52,328,000 after acquiring an additional 49,214 shares during the period. 62.73% of the stock is currently owned by institutional investors.
Analyst Ratings Changes
A number of analysts have recently issued reports on the stock. Jefferies Financial Group set a $450.00 price objective on shares of HCA Healthcare in a research note on Tuesday, July 14th. TD Cowen cut their price target on HCA Healthcare from $500.00 to $431.00 and set a “buy” rating for the company in a research note on Monday, June 22nd. Sanford C. Bernstein reaffirmed a “market perform” rating on shares of HCA Healthcare in a research note on Wednesday, July 15th. JPMorgan Chase & Co. lowered their price target on HCA Healthcare from $490.00 to $425.00 and set a “neutral” rating on the stock in a report on Thursday, August 20th. Finally, Mizuho cut their price objective on shares of HCA Healthcare from $525.00 to $475.00 and set an “outperform” rating for the company in a report on Tuesday, July 28th. Fourteen research analysts have rated the stock with a Buy rating, eight have issued a Hold rating and one has given a Sell rating to the company’s stock. Based on data from MarketBeat, the stock has an average rating of “Moderate Buy” and a consensus target price of $462.64.
HCA Healthcare Trading Down 1.9%
Shares of HCA stock opened at $419.19 on Friday. The stock’s 50-day moving average price is $400.24 and its 200-day moving average price is $441.63. HCA Healthcare, Inc. has a 12-month low of $353.99 and a 12-month high of $556.52. The stock has a market capitalization of $90.75 billion, a price-to-earnings ratio of 14.03, a price-to-earnings-growth ratio of 1.48 and a beta of 1.10.
HCA Healthcare (NYSE:HCA – Get Free Report) last released its quarterly earnings results on Friday, July 24th. The company reported $7.59 earnings per share for the quarter, beating the consensus estimate of $7.56 by $0.03. The business had revenue of $20.23 billion during the quarter, compared to analysts’ expectations of $19.76 billion. HCA Healthcare had a negative return on equity of 244.79% and a net margin of 8.77%.The firm’s revenue for the quarter was up 8.7% compared to the same quarter last year. During the same quarter last year, the business posted $6.84 EPS. As a group, research analysts predict that HCA Healthcare, Inc. will post 29.42 EPS for the current fiscal year.
HCA Healthcare Dividend Announcement
The firm also recently disclosed a quarterly dividend, which will be paid on Wednesday, September 30th. Shareholders of record on Wednesday, September 16th will be given a dividend of $0.78 per share. The ex-dividend date is Wednesday, September 16th. This represents a $3.12 annualized dividend and a yield of 0.7%. HCA Healthcare’s dividend payout ratio (DPR) is 10.45%.
About HCA Healthcare
HCA Healthcare is a for‑profit operator of healthcare facilities headquartered in Nashville, Tennessee. Founded in 1968, the company owns and operates a network of hospitals and related healthcare facilities and has grown through organic expansion and acquisitions to become a large provider of inpatient and outpatient services.
The company’s core activities include the operation of acute care hospitals, freestanding surgical and emergency centers, and outpatient clinics. HCA’s services encompass inpatient care, surgical services, emergency medicine, diagnostic imaging and laboratory testing, and various outpatient and ambulatory care offerings.
Further Reading
- Five stocks we like better than HCA Healthcare
- Nutanix’s Rally Has a Bigger Story Than Earnings as AMD’s AI Bet Takes Shape
- SEC Probe Puts Wall Street Leverage Risk Back in Focus
- A Bearish-Dollar Options Surge Raises the Stakes for Warsh at Jackson Hole
- Five Below’s Turnaround Is Working—But Has the Stock Run Too Far?
Want to see what other hedge funds are holding HCA? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for HCA Healthcare, Inc. (NYSE:HCA – Free Report).
Receive News & Ratings for HCA Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for HCA Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.
